These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2547680)

  • 1. Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children.
    Drummond K; Levy-Marchal C; Laborde K; Kindermans C; Wright C; Dechaux M; Czernichow P
    Diabetologia; 1989 Apr; 32(4):255-60. PubMed ID: 2547680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
    Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.
    Baba T; Murabayashi S; Takebe K
    Diabetologia; 1989 Jan; 32(1):40-4. PubMed ID: 2540054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
    Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P
    BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients.
    Pedersen MM; Schmitz A; Pedersen EB; Danielsen H; Christiansen JS
    Diabet Med; 1988 Sep; 5(6):562-9. PubMed ID: 2850132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
    Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect.
    Rudberg S; Aperia A; Freyschuss U; Persson B
    Diabetologia; 1990 Aug; 33(8):470-6. PubMed ID: 2170218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
    Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal effects of angiotensin converting enzyme inhibition in microalbuminuric type 1 diabetic patients.
    Hansen KW; Pedersen MM; Christiansen JS; Mogensen CE
    Acta Diabetol; 1993; 30(3):149-53. PubMed ID: 8111075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
    de Azevedo MJ; Ramos OL; Gross JL
    Horm Metab Res; 1997 Oct; 29(10):516-9. PubMed ID: 9405980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of enalapril on the development of diabetic nephropathy in children and adolescents].
    Lebl J; Kolousková S; Snajderová M
    Cesk Pediatr; 1991 Mar; 46(3):149-52. PubMed ID: 1893436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M; Brosh D; Levi Z; Bar-Dayan Y; Ravid D; Rachmani R
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.
    Hallab M; Gallois Y; Chatellier G; Rohmer V; Fressinaud P; Marre M
    BMJ; 1993 Jan; 306(6871):175-82. PubMed ID: 8443481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes.
    Cherney DZ; Sochett EB; Miller JA
    Kidney Int; 2005 Oct; 68(4):1722-8. PubMed ID: 16164648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
    Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
    Hoogenberg K; Navis G; Dullaart RP
    Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.